Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete ...

Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced the publication of foundational data in Molecular Therapy ...

Announced in June, positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across ...

A gene therapy called AMT-130 appears to be the first treatment to slow the progression of Huntington’s disease, an inherited ...

Professor Paul Gissen told delegates at ELRIG 2026 that gene therapy has begun to change the outlook for some childhood ...

PRIALT is a non-opioid intrathecal analgesic indicated for the management of severe chronic pain in patients for whom intrathecal therapy is warranted and who are intolerant of or refractory to other ...

Anthropic is suing the Department of Defense and other federal agencies on Monday over the Trump administration’s decision to label the AI company a “supply chain risk.” The lawsuit is the latest ...

Seventeen Democratic-led states sued the Trump administration on Wednesday over new race-based reporting requirements for universities targeting admissions, financial aid and student performance data.

An in-depth look at the immigration, environment, economy and foreign policies of the Trump administration, from the Los Angeles Times. Viktor Orbán, the EU’s longest-serving leader, has trailed in ...

The SCI treatment pipeline continues to expand, featuring candidates such as KP-100IT (Kringle Pharma), Neuro-Cells ...

Every time Talia publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...